Investors: Huons, Samyang Holdings, KTB Network, Daily Partners, DSC Investment, KDB Capital, Maple Investment, KB Securities
Announcement: 19/04/21
Country: East Asia
Company name: PharmCADD
Website: http://pharmcadd.com
Email address: [email protected]
Phone: 82 2 564 5688
Contact: Mr. Taehyung Kwon, Founder
Headquarter: South Korea
Funding Round: Series B
Funding amount: $16 million
Total funding to date: $16 million
Valuation: Undisclosed
About company: Utilizing state-of-the-art technologies of deep neural networks, molecular dynamics simulation, quantum calculation and network theory, Pharmulator™, our innovative artificial intelligence (AI)-based drug discovery platform, is poised to help global scientists tackle the most demanding challenges across the whole spectrum of drug discovery process. PharmCADD, we relentlessly work hard to become a reliable navigator and partner for drug discovery.